Development of an external quality assurance (EQA) structure to evaluate the quality of genetic pathology reporting

IF 2.9 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinica Chimica Acta Pub Date : 2025-05-15 Epub Date: 2025-03-25 DOI:10.1016/j.cca.2025.120263
Tony Badrick , Jason Tseung , Maddison Frogley , Sze Yee Chai , Brett A. Lidbury
{"title":"Development of an external quality assurance (EQA) structure to evaluate the quality of genetic pathology reporting","authors":"Tony Badrick ,&nbsp;Jason Tseung ,&nbsp;Maddison Frogley ,&nbsp;Sze Yee Chai ,&nbsp;Brett A. Lidbury","doi":"10.1016/j.cca.2025.120263","DOIUrl":null,"url":null,"abstract":"<div><div>A standard for reporting genetic pathology results currently does not exist as a consensus. While effective reports are produced, there is lack of consistency on which details to present or to emphasise, and the ultimate report often reflects an individual practitioner’s preferences derived from anecdotal experience. Genetic knowledge is complex, so poor and/or inconsistent reporting could make the application of pathology results to patient management more challenging than necessary. The aim of this study was to combine expert knowledge with machine learning (ML) applications to design a template to encourage consistent and accurate genetic reporting. To investigate genetic reporting quality within Australasia, past melanoma genetics reports produced in response to RCPA Quality Assurance Program (RCPAQAP) audits were compiled for retrospective text analyses to determine word frequencies and patterns. These text pattern analyses were supported by an investigation of reporting criteria consistency for solid tumours, as well as a narrative review of the broader literature, by a genetic pathology expert to contextualise these results, with the ultimate results combined into a suggested template. These results will be augmented via further ML studies on report structure.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"572 ","pages":"Article 120263"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125001421","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A standard for reporting genetic pathology results currently does not exist as a consensus. While effective reports are produced, there is lack of consistency on which details to present or to emphasise, and the ultimate report often reflects an individual practitioner’s preferences derived from anecdotal experience. Genetic knowledge is complex, so poor and/or inconsistent reporting could make the application of pathology results to patient management more challenging than necessary. The aim of this study was to combine expert knowledge with machine learning (ML) applications to design a template to encourage consistent and accurate genetic reporting. To investigate genetic reporting quality within Australasia, past melanoma genetics reports produced in response to RCPA Quality Assurance Program (RCPAQAP) audits were compiled for retrospective text analyses to determine word frequencies and patterns. These text pattern analyses were supported by an investigation of reporting criteria consistency for solid tumours, as well as a narrative review of the broader literature, by a genetic pathology expert to contextualise these results, with the ultimate results combined into a suggested template. These results will be augmented via further ML studies on report structure.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
开发外部质量保证(EQA)结构以评估遗传病理报告的质量。
目前,遗传病理学结果的报告标准尚未形成共识。虽然报告效果显著,但在呈现或强调哪些细节方面却缺乏一致性,最终报告往往反映了个别从业者根据轶事经验得出的偏好。遗传学知识是复杂的,因此报告不完善和/或不一致会使病理结果在患者管理中的应用比必要时更具挑战性。本研究的目的是将专家知识与机器学习(ML)应用相结合,设计一个模板来鼓励一致、准确的基因报告。为了调查澳大拉西亚地区的基因报告质量,我们汇编了过去根据RCPA质量保证计划(RCPAQAP)审核结果撰写的黑色素瘤基因报告,并进行了回顾性文本分析,以确定词频和模式。在进行这些文本模式分析的同时,遗传病理学专家还对实体瘤的报告标准一致性进行了调查,并对更广泛的文献进行了叙述性综述,以便对这些结果进行背景分析,最终将结果合并为一个建议模板。这些结果将通过对报告结构的进一步多变量研究得到补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinica Chimica Acta
Clinica Chimica Acta 医学-医学实验技术
CiteScore
10.10
自引率
2.00%
发文量
1268
审稿时长
23 days
期刊介绍: The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
期刊最新文献
Beyond cholesterol: targeting inflammatory biomarkers in cardiovascular disease Extracellular vesicles in cardiovascular disease: Biomarkers, therapeutic applications, and drug delivery strategies Metabolomics biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis Recommendations for establishing metrological traceability for in vitro diagnostic measurement procedures intended to be used for whole blood samples The label-free electrochemical S100B-TBI immunosensor for sensitive detection of S100B protein as a biomarker for traumatic brain injury using FFT-SWV voltammetry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1